MBPL3621 Introduction to Pharmacology Quiz 1 – 33 MCQs | Kenya MBChB

33 Year 3: Basic Pharmacology II exam questions on MBPL3621 Introduction to Pharmacology Quiz 1 for medical students. Includes MCQs, answers, explanations and w

This MCQ set contains 33 questions on MBPL3621 Introduction to Pharmacology Quiz 1 in the Year 3: Basic Pharmacology II unit. Each question includes the correct answer and a detailed explanation for active recall and exam preparation.

Q1: Which process involves the transfer of a drug from its site of administration to the blood stream?

  1. A. Absorption
  2. B. Metabolism
  3. C. Excretion
  4. D. Distribution

Correct answer: A – Absorption

Absorption is the movement of a drug from its site of administration into the bloodstream. This process is essential for the drug to reach systemic circulation and eventually its site of action. ---

Q2: Receptor agonists result in a drug response.

  1. A. True
  2. B. False
  3. C. True
  4. D. This is the mechanism by which many drugs exert their therapeutic effects.

Correct answer: A – True

Receptor agonists bind to receptors and activate them, producing a biological response. This is the mechanism by which many drugs exert their therapeutic effects. ---

Q3: Glomerular filtration of a drug is affected by its:

  1. A. Rate of tubular secretion
  2. B. Plasma protein binding
  3. C. Lipid solubility
  4. D. Degree of ionization

Correct answer: B – Plasma protein binding

Only free (unbound) drug molecules can be filtered through the glomerulus. Drugs bound to plasma proteins are too large to pass through the glomerular membrane, so plasma protein binding directly affects glomerular filtration. ---

Q4: For the calculation of the volume of distribution (Vd) one must take into account:

  1. A. Therapeutic window of the drug
  2. B. Concentration of a substance in plasma
  3. C. The dose of the drug
  4. D. Concentration of substance in urine

Correct answer: B – Concentration of a substance in plasma

Volume of distribution (Vd) is calculated using the formula: Vd = Dose / Plasma concentration. It represents the theoretical volume needed to contain the total amount of drug at the same concentration as in plasma. ---

Q5: This illustration below is concerned with which factor that influences the response to drug therapy.

  1. A. Patient compliance
  2. B. Rate of metabolism and excretion
  3. C. Drug-receptor interaction
  4. D. Placebo effects

Correct answer: B – Rate of metabolism and excretion

The illustration focuses on pharmacokinetics (how the body processes the drug), not pharmacodynamics (drug effects). Metabolism and excretion are pharmacokinetic processes that determine drug concentration over time. ---

Q6: The strength of the drug is related to the dose of the drug.

  1. A. True
  2. B. False
  3. C. True
  4. D. g., 500 mg tablet). Higher doses contain more drug and therefore have greater strength, though this is different from potency, which is a comparative

Correct answer: A – True

Strength refers to the amount of drug in a dosage form (e.g., 500 mg tablet). Higher doses contain more drug and therefore have greater strength, though this is different from potency, which is a comparative measure. ---

Q7: What does "pharmacokinetics" include?

  1. A. Influence of drugs on metabolism processes
  2. B. Drug biotransformation in the organism
  3. C. Complications of drug therapy
  4. D. Influence of drugs on genes

Correct answer: B – Drug biotransformation in the organism

Pharmacokinetics describes what the body does to the drug, including absorption, distribution, metabolism (biotransformation), and excretion (ADME). ---

Q8: Drugs which undergo high degree of first-pass metabolism in liver:

  1. A. Are contraindicated in liver disease
  2. B. Go through elimination
  3. C. Have low oral bioavailability
  4. D. Are excreted primarily in bile

Correct answer: C – Have low oral bioavailability

First-pass metabolism occurs when orally administered drugs are metabolized in the liver before reaching systemic circulation, reducing the amount of active drug available and thus decreasing oral bioavailability. ---

Q9: Bioavailability of drug refers to:

  1. A. All the choices
  2. B. Ratio of drug excreted unchanged in urine to that excreted as metabolites
  3. C. None of the choices
  4. D. Ratio of orally administered drug to that excreted in the faeces
  5. E. Percentage of administered dose that reaches systemic circulation in the changed form - F. Ratio of oral dose to parenteral dose

Correct answer: C – None of the choices

Bioavailability is the percentage of administered dose that reaches systemic circulation in the UNCHANGED (active) form, not "changed form" as stated in option E. None of the provided options correctly defines bioavailability. ---

Q10: Question 11 Receptor antagonists result in a drug response. Choices:

  1. A. False -
  2. B. True
  3. C. False
  4. D. ---

Correct answer: A – False -

Receptor antagonists bind to receptors but do not activate them. They block the receptor and prevent agonists from binding, thereby inhibiting a response rather than producing one. ---

Q11: Which of the following are sources for making drugs?

  1. A. Animals
  2. B. Plants
  3. C. None of the choices
  4. D. Synthetic
  5. E. All the choices

Correct answer: E – All the choices

Drugs can be derived from multiple sources including animals (e.g., insulin), plants (e.g., morphine), and synthetic/chemical synthesis (e.g., aspirin). Modern pharmaceuticals use all these sources. ---

Q12: Which process affects bioavailability?

  1. A. Metabolism
  2. B. Distribution
  3. C. Excretion
  4. D. Absorption

Correct answer: D – Absorption

Bioavailability is primarily determined by absorption and first-pass metabolism. The extent and rate of absorption directly affect how much drug reaches systemic circulation. ---

Q13: Biotransformation of drugs is primarily directed to:

  1. A. Inactivate the drug
  2. B. Activate the drug
  3. C. Convert non-lipid soluble drugs into lipid soluble metabolites
  4. D. Convert lipid soluble drugs into non-lipid soluble metabolites
  5. E. metabolites, facilitating their excretion through urine or bil

Correct answer: D – Convert lipid soluble drugs into non-lipid soluble metabolites

Biotransformation (metabolism) typically converts lipid-soluble drugs into more water-soluble (non-lipid soluble) metabolites, facilitating their excretion through urine or bile. ---

Q14: The volume of distribution (Vd) relates to:

  1. A. Single to a daily dose of an administrated drug
  2. B. The amount of drug concentrated in the blood plasma
  3. C. The theoretical volume that contains the total concentration of an administered drug
  4. D. Unchanged drug reaching the systemic circulation
  5. E. It indicates the extent of drug distribution in body tissues.

Correct answer: A – Single to a daily dose of an administrated drug

Volume of distribution is the theoretical volume necessary to contain the total amount of administered drug at the same concentration observed in blood plasma. It indicates the extent of drug distribution in body tissues. ---

Q15: The reasons determining bioavailability are:

  1. A. Extent of absorption and hepatic first-pass effect
  2. B. Rheological parameters of blood
  3. C. Glomerular filtration rate
  4. D. Amount of a substance obtained orally and quantity of intakes

Correct answer: A – Extent of absorption and hepatic first-pass effect

Bioavailability is primarily determined by how much drug is absorbed and how much undergoes first-pass metabolism in the liver before reaching systemic circulation. ---

Q16: All of the following statements about efficacy and potency are true EXCEPT:

  1. A. The ED50 is a measure of drug's efficacy
  2. B. Efficacy is the maximum effect of a drug
  3. C. Efficacy is usually a more important clinical consideration than potency
  4. D. Potency is a comparative measure, refers to the different doses of two drugs that are needed to produce the same effect

Correct answer: A – The ED50 is a measure of drug's efficacy

ED50 (effective dose in 50% of population) is a measure of potency, not efficacy. Efficacy refers to the maximum effect a drug can produce, regardless of dose. ---

Q17: Which of the following cytochrome P450 isoenzymes is involved in the metabolism of largest number of drugs in human beings and has been implicated in some dangerous drug interactions:

  1. A. CYP 1A2
  2. B. CYP 2E1
  3. C. CYP 3A4
  4. D. CYP2C9

Correct answer: C – CYP 3A4

CYP3A4 is responsible for metabolizing approximately 50% of all drugs and is frequently involved in clinically significant drug-drug interactions. ---

Q18: A prodrug is:

  1. A. A drug that is stored in body tissues and is then gradually released in the circulation
  2. B. The oldest member of a class of drugs
  3. C. An inactive drug that is transformed in the body to an active metabolite
  4. D. The prototype member of a class of drugs

Correct answer: C – An inactive drug that is transformed in the body to an active metabolite

A prodrug is administered in an inactive or less active form and is metabolized in the body to produce the active drug. This approach can improve drug absorption, distribution, or reduce side effects. ---

Q19: Which process is concerned with the blood brain barrier, tissue storage and plasma protein binding?

  1. A. Absorption
  2. B. Metabolism
  3. C. Distribution
  4. D. Excretion

Correct answer: C – Distribution

Distribution involves the movement of drug from circulation to tissues and is affected by barriers (like blood-brain barrier), tissue binding, and plasma protein binding. ---

Q20: Which of the following is pharmacokinetic parameter used to monitor the elimination phase of a drug?

  1. A. Absorption
  2. B. Bioavailability
  3. C. Plasma half life
  4. D. Volume of distribution

Correct answer: C – Plasma half life

Plasma half-life (t½) is the time required for the plasma concentration of a drug to decrease by 50%. It is the primary parameter used to monitor and characterize drug elimination. ---

Q21: The most commonly occurring conjugation reaction for drugs and their metabolites is:

  1. A. Glucuronidation
  2. B. Methylation
  3. C. Glutathione conjugation
  4. D. Acetylation

Correct answer: A – Glucuronidation

Glucuronidation is the most common Phase II conjugation reaction, involving the addition of glucuronic acid to drugs or their metabolites, making them more water-soluble for excretion. ---

Q22: What is the reason of complicated penetration of some drugs through brain-blood barrier?

  1. A. Absence of pores in the brain capillary endothelium
  2. B. High endocytosis degree in a brain capillary
  3. C. High lipid solubility of a drug
  4. D. Meningitis - inflamed meninges making the BBB more porous

Correct answer: A – Absence of pores in the brain capillary endothelium

The blood-brain barrier has tight junctions between endothelial cells with no pores, making it difficult for many drugs to penetrate. Only lipid-soluble drugs or those with specific transporters can cross easily. ---

Q23: Which process involves the drug being metabolized in the liver before reaching systemic circulation?

  1. A. Metabolism
  2. B. Distribution
  3. C. Absorption
  4. D. Excretion

Correct answer: A – Metabolism

This describes first-pass metabolism, where orally administered drugs are metabolized in the liver (or gut wall) before reaching systemic circulation, reducing bioavailability. ---

Q24: Correct statements listing characteristics of a particular route of drug administration include all of the following EXCEPT:

  1. A. Subcutaneous administration may cause local irritation
  2. B. Intramuscular administration requires a sterile technique
  3. C. Intravenous administration provides a rapid response
  4. D. Inhalation provides slow access to the general circulation

Correct answer: D – Inhalation provides slow access to the general circulation

Inhalation actually provides rapid access to systemic circulation due to the large surface area and rich blood supply of the lungs, not slow access. ---

Q25: Which process involves the passage of drug from the circulation to the tissue and site of its action?

  1. A. Excretion
  2. B. Distribution
  3. C. Absorption
  4. D. Metabolism

Correct answer: B – Distribution

Distribution is the process by which a drug reversibly moves from the bloodstream into tissues and the site of action. ---

View on OmpathStudy